Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Ruiz

Showing results (311-320 of 539) with videos related to

Pageof 54
Sort By:
Journal of Autoimmunity|March 1, 2011
Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factorsMarta Ruiz-Riol, Maria del Pilar Armengol Barnils, Roger Colobran Oriol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathwayYusuke Suzuki, Carmen Gómez-Guerrero, Isao Shirato, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 21, 2011
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin IIMaria D Sanchez-Niño, Ana B Sanz, Elsa Sanchez-Lopez, et al.
The Journal of Pathology|September 17, 2013
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammationSandra Rayego-Mateos, Jose Luis Morgado-Pascual, Ana Belen Sanz, et al.
Journal of Clinical Medicine|August 5, 2015
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeMaria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, et al.
Cancer Immunology, Immunotherapy : CII|December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma modelDiana Llopiz, Marta Ruiz, Lorea Villanueva, et al.
Molecular and Cellular Endocrinology|April 2, 2021
Renin-angiotensin system and inflammation updateElena Cantero-Navarro, Beatriz Fernández-Fernández, Adrian M Ramos, et al.
Neurology|August 8, 2022
Pearls & Oy-sters: Challenges and Controversies in Wilson DiseaseMarta Ruiz-Lopez, Ana Moreno Estébanez, Beatriz Tijero, et al.
Children (Basel, Switzerland)|July 29, 2025
Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator TherapiesGuillermo García-Pérez-de-Sevilla, Ángela Blanco Velasco, Thomas Yvert, et al.
Clinical Transplantation|March 2, 2011
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patientsBeatriz Tavira, Eliecer Coto, Carmen Díaz-Corte, et al.
Pageof 54

Showing results (311-320 of 539) with videos related to

Sort By:
Pageof 54
Journal of Autoimmunity|March 1, 2011
Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factorsMarta Ruiz-Riol, Maria del Pilar Armengol Barnils, Roger Colobran Oriol, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathwayYusuke Suzuki, Carmen Gómez-Guerrero, Isao Shirato, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 21, 2011
HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin IIMaria D Sanchez-Niño, Ana B Sanz, Elsa Sanchez-Lopez, et al.
The Journal of Pathology|September 17, 2013
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammationSandra Rayego-Mateos, Jose Luis Morgado-Pascual, Ana Belen Sanz, et al.
Journal of Clinical Medicine|August 5, 2015
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeMaria Vanessa Perez-Gomez, Maria Dolores Sanchez-Niño, Ana Belen Sanz, et al.
Cancer Immunology, Immunotherapy : CII|December 15, 2018
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma modelDiana Llopiz, Marta Ruiz, Lorea Villanueva, et al.
Molecular and Cellular Endocrinology|April 2, 2021
Renin-angiotensin system and inflammation updateElena Cantero-Navarro, Beatriz Fernández-Fernández, Adrian M Ramos, et al.
Neurology|August 8, 2022
Pearls & Oy-sters: Challenges and Controversies in Wilson DiseaseMarta Ruiz-Lopez, Ana Moreno Estébanez, Beatriz Tijero, et al.
Children (Basel, Switzerland)|July 29, 2025
Respiratory Muscle Function in Children and Adolescents with Cystic Fibrosis in the Era of CFTR Modulator TherapiesGuillermo García-Pérez-de-Sevilla, Ángela Blanco Velasco, Thomas Yvert, et al.
Clinical Transplantation|March 2, 2011
KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patientsBeatriz Tavira, Eliecer Coto, Carmen Díaz-Corte, et al.
Pageof 54